The World Health Organisation (WHO) has approved a COVID-19 vaccine made by Sinovac Biotech for emergency use listing.
It's the second Chinese-produced shot to get its endorsement, a WHO statement said on Tuesday.
WHO emergency listing is a signal to national regulators on a product's safety and efficacy.
It would also allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries, which currently faces major supply problems.
In a statement, the independent panel of experts said it recommended Sinovac's vaccine for adults over 18, with a second dose 2-4 weeks later.
There was no upper age limit as data suggested it is likely to have a protective effect in older people.
US and Iran exchange attacks as lull in war appears over
Kuwait confirms no injuries after Iranian drone hits residential complex
Nepal flood rescue hopes dim as China restores access to Tibet disaster zone
At least 21 die in bus accident in Egypt's South Sinai, ministry says
Defendant pleads not guilty in Charlie Kirk capital murder case
